|
1
|
Shi J, Fu H, Jia Z, He K, Fu L and Wang W:
High expression of CPT1A predicts adverse outcomes: A potential
therapeutic target for acute myeloid leukemia. EBiomedicine.
14:55–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Granito A, Marinelli S, Negrini G, Menetti
S, Benevento F and Bolondi L: Prognostic significance of adverse
events in patients with hepatocellular carcinoma treated with
sorafenib. Ther Adv Gastroenterol. 9:240–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiaobin C, Zhaojun X, Tao L, Tianzeng D,
Xuemei H, Fan Z, Chunyin H, Jianqiang H and Chen L: Analysis of
related risk factors and prognostic factors of gastric cancer with
bone metastasis: A SEER-based study. J Immunol Res.
2022:32510512022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhong Y, Kang W, Hu H, Li W, Zhang J and
Tian Y: Lobaplatin-based prophylactic hyperthermic intraperitoneal
chemotherapy for T4 gastric cancer patients: A retrospective
clinical study. Front Oncol. 13:9956182023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J, Wei H, Liu M, Huang T, Fang X, Ren
X, Huang T, Fang X, Ren X, Yuan H, et al: Prognostic biomarker HAMP
and associates with immune infiltration in gastric cancer. Int
Immunopharmacol. 108:1088392022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim YH, Jeong DC, Pak K, Han ME, Kim JY,
Liangwen L, Kim HJ, Kim TW, Kim TH, Hyun DW and Oh SO: SLC2A2
(GLUT2) as a novel prognostic factor for hepatocellular carcinoma.
Oncotarget. 8:68381–68392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv
L, Liu J, Xu Y, Shen Y and Yang M: Noncoding RNAs in gastric
cancer: Implications for drug resistance. Mol Cancer. 19:622020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding N, Zou Z, Sha H, Su S, Qian H, Meng
F, Chen F, Du S, Zhou S, Chen H, et al: iRGD synergizes with PD-1
knockout immunotherapy by enhancing lymphocyte infiltration in
gastric cancer. Nat Commun. 10:13362019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi H, Wang H, Pan J, Liu Z and Li Z:
Comparing prognostic value of preoperative platelet indexes in
patients with resectable gastric cancer. Sci Rep. 12:64802022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mukhopadhyay P, Ye J, Anderson KM,
Roychoudhury S, Rubin EH, Halabi S and Chappell RJ: Log-rank test
vs MaxCombo and difference in restricted mean survival time tests
for comparing survival under nonproportional hazards in
immuno-oncology trials: A systematic review and meta-analysis. JAMA
Oncol. 8:1294–1300. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sperduto PW, Yang TJ, Beal K, Pan H, Brown
PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, et al:
Estimating survival in patients with lung cancer and brain
metastases: An update of the graded prognostic assessment for lung
cancer using molecular markers (lung-molGPA). JAMA Oncol.
3:827–831. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abu N, Othman N, W Hon K, Nazarie WF and
Jamal R: Integrative meta-analysis for the identification of hub
genes in chemoresistant colorectal cancer. Biomark Med. 14:525–537.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshikawa T, Inoue R, Matsumoto M, Yajima
T, Ushida K and Iwanaga T: Comparative expression of hexose
transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse
gastrointestinal tract. Histochem Cell Biol. 135:183–194. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Liu Y, Huang J, Hu Z and Miao Y:
Identification of new head and neck squamous cell carcinoma
subtypes and development of a novel score system (PGSscore) based
on variations in pathway activity between tumor and adjacent
non-tumor samples. Comput Struct Biotechnol J. 20:4786–4805. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pasini FS, Zilberstein B, Snitcovsky I,
Roela RA, Mangone FR, Ribeiro UJ Jr, Nonogaki S, Brito GC,
Callegari GD, Cecconello I, et al: A gene expression profile
related to immune dampening in the tumor microenvironment is
associated with poor prognosis in gastric adenocarcinoma. J
Gastroenterol. 49:1453–1466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon SJ, Park J, Shin Y, Choi Y, Park SW,
Kang SG, Son HY and Huh YM: Deconvolution of diffuse gastric cancer
and the suppression of CD34 on the BALB/c nude mice model. BMC
Cancer. 20:3142020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Manning L, O'Rourke KI, Knowles DP, Marsh
SA, Spencer YI, Moffat E, Wells GA and Czub S: A collaborative
Canadian-United Kingdom evaluation of an immunohistochemistry
protocol to diagnose bovine spongiform encephalopathy. J Vet Diagn
Invest. 20:504–508. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin Y, Liu H, Huang X, Huang L, Liao L, Li
J, Zhang L, Li W and Yang J: GIMAP7 as a potential predictive
marker for pan-cancer prognosis and immunotherapy efficacy. J
Inflamm Res. 15:1047–1061. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He J, Chen Z, Xue Q, Sun P, Wang Y, Zhu C
and Shi W: Identification of molecular subtypes and a novel
prognostic model of diffuse large B-cell lymphoma based on a
metabolism-associated gene signature. J Transl Med. 20:1862022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Xue H, Xiang Z, Song S, Yan R, Ji J,
Zhu Z, Wei C and Yu Y: Genetic profiles affect the biological
effects of serine on gastric cancer cells. Front Pharmacol.
11:11832020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seeneevassen L, Giraud J, Molina-Castro S,
Sifré E, Tiffon C, Beauvoit C, Staedel C, Mégraud F, Lehours P,
Martin OCB, et al: Leukaemia inhibitory factor (LIF) inhibits
cancer stem cells tumorigenic properties through hippo kinases
activation in gastric cancer. Cancers (Basel). 12:20112020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma J, Chen M, Wang J, Xia HH, Zhu S, Liang
Y, Gu Q, Qiao L, Dai Y, Zou B, et al: Pancreatic duodenal
homeobox-1 (PDX1) functions as a tumor suppressor in gastric
cancer. Carcinogenesis. 29:1327–1333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Fang Y, Zhao F, Gu J, Lv X, Xu R,
Zhang B, Fang Z and Li Y: Identification of GGT5 as a novel
prognostic biomarker for gastric cancer and its correlation with
immune cell infiltration. Front Genet. 13:8102922022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu W, Sun T, Wang J, Li H, Chen B, Zhou Y,
Wang T, Wang S, Liu J and Jiang H: LMO3 downregulation in PCa: A
prospective biomarker associated with immune infiltration. Front
Genet. 13:9451512022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang
S, Dong S, Wen Z, Rao J, Liao W and Shi M: The lncRNA MACC1-AS1
promotes gastric cancer cell metabolic plasticity via AMPK/Lin28
mediated mRNA stability of MACC1. Mol Cancer. 17:692018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Osumi H, Horiguchi H, Kadomatsu T, Tashiro
K, Morinaga J, Takahashi T, Ikeda K, Ito T, Suzuki M, Endo M and
Oike Y: Tumor cell-derived angiopoietin-like protein 2 establishes
a preference for glycolytic metabolism in lung cancer cells. Cancer
Sci. 111:1241–1253. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo F, Liu X, Yan N, Li S, Cao G, Cheng Q,
Xia Q and Wang H: Hypoxia-inducible transcription factor-1alpha
promotes hypoxia-induced A549 apoptosis via a mechanism that
involves the glycolysis pathway. BMC Cancer. 6:262006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SL, Lee ST, Min IS, Park YR, Lee JH,
Kim DG and Kim SW: Lipocalin 2 negatively regulates cell
proliferation and epithelial to mesenchymal transition through
changing metabolic gene expression in colorectal cancer. Cancer
Sci. 108:2176–2186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krawczyk M, Pastuch-Gawolek G, Pluta A,
Erfurt K, Dominski A and Kurcok P: 8-hydroxyquinoline
glycoconjugates: Modifications in the linker structure and their
effect on the cytotoxicity of the obtained compounds. Molecules.
24:41812019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang N, Chen S, Zhang B, Li S, Jin F, Gao
D, Liu H and Jiang Y: 8u, a pro-apoptosis/cell cycle arrest
compound, suppresses invasion and metastasis through HSP90α
downregulating and PI3K/Akt inactivation in hepatocellular
carcinoma cells. Sci Rep. 8:3092018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zuo D, Li C, Liu T, Yue M, Zhang J and
Ning G: Construction and validation of a metabolic risk model
predicting prognosis of colon cancer. Sci Rep. 11:68372021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cohnen J, Kornstädt L, Hahnefeld L,
Ferreiros N, Pierre S, Koehl U, Deller T, Geisslinger G and
Scholich K: Tumors provoke inflammation and perineural microlesions
at adjacent peripheral nerves. Cells. 9:3202020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang N, Zhang Z, Chen X, Zhang G, Wang Y,
Pan L, Yan C, Yang G, Zhao L, Han J and Xue T: Plasma lipidomics
profiling reveals biomarkers for papillary thyroid cancer
diagnosis. Front Cell Dev Biol. 9:6822692021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Y, Li H, Fan L, Chen Y, Li L, Zhou X,
Li R, Cheng Y, Chen H and Yuan Z: Development of
photosensitizer-loaded lipid droplets for photothermal therapy
based on thiophene analogs. J Adv Res. 28:165–174. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng M, Mullikin H, Hester A, Czogalla B,
Heidegger H, Vilsmaier T, Vattai A, Chelariu-Raicu A, Jeschke U,
Trillsch F, et al: Development and validation of a novel 11-gene
prognostic model for serous ovarian carcinomas based on lipid
metabolism expression profile. Int J Mol Sci. 21:91692020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Zhang S, Wang Q and Zhang X:
Tumor-recruited M2 macrophages promote gastric and breast cancer
metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol
Oncol. 10:362017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Messex JK, Byrd CJ and Liou GY: Signaling
of macrophages that contours the tumor microenvironment for
promoting cancer development. Cells. 9:9192020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yuan J, Liang H, Li J, Li M, Tang B, Ma H,
Xie X, Yin X, Zhang L and Ren Z: Peripheral blood neutrophil count
as a prognostic factor for patients with hepatocellular carcinoma
treated with sorafenib. Mol Clin Oncol. 7:837–842. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li X, Li Y, Lu W, Chen M, Ye W and Zhang
D: The tumor vessel targeting strategy: A double-edged sword in
tumor metastasis. Cells. 8:16022019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Siracusano G, Tagliamonte M, Buonaguro L
and Lopalco L: Cell surface proteins in hepatocellular carcinoma:
From bench to bedside. Vaccines (Basel). 8:412020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Brodsky AS, Khurana J, Guo KS, Wu EY, Yang
D, Siddique AS, Wong IY, Gamsiz Uzun ED and Resnick MB: Somatic
mutations in collagens are associated with a distinct tumor
environment and overall survival in gastric cancer. BMC Cancer.
22:1392022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cao L, Che X, Qiu X, Li Z, Yang B, Wang S,
Hou K, Fan Y, Qu X and Liu Y: M2 macrophage infiltration into tumor
islets leads to poor prognosis in non-small-cell lung cancer.
Cancer Manag Res. 11:6125–6138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Meng J, Chen Y, Lu X, Ge Q, Yang F, Bai S,
Liang C and Du J: Macrophages and monocytes mediated activation of
oxidative phosphorylation implicated the prognosis and clinical
therapeutic strategy of wilms tumour. Comput Struct Biotechnol J.
20:3399–3408. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang Z, Yang H, Lao J and Deng W: Solute
carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and
correlated with immune infiltration in stomach adenocarcinoma. PLoS
One. 18:e2873032023.
|
|
46
|
Chen L, Diao L, Yang Y, Yi X, Rodriguez
BL, Li Y, Villalobos PA, Cascone T, Liu X, Tan L, et al:
CD38-mediated immunosuppression as a mechanism of tumor cell escape
from PD-1/PD-L1 blockade. Cancer Discov. 8:1156–1175. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim Y, Song S, Lee M, Swatloski T, Kang
JH, Ko YH, Park WY, Jeong HS and Park K: Integrative genomic
analysis of salivary duct carcinoma. Sci Rep. 10:149952020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu W, Yang LJ, Liu YL, Yuan DS, Zhao ZM,
Wang Q, Yan Y and Pan HF: Dynamic characterization of intestinal
metaplasia in the gastric corpus mucosa of Atp4a-deficient mice.
Biosci Rep. 40:BSR201818812020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yuan LW, Yamashita H and Seto Y: Glucose
metabolism in gastric cancer: The cutting-edge. World J
Gastroenterol. 22:2046–2059. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang J, Fang Y and Liu T: TRIM32 promotes
the growth of gastric cancer cells through enhancing AKT activity
and glucose transportation. Biomed Res Int.
2020:40276272020.PubMed/NCBI
|
|
51
|
Kim WS, Kim YY, Jang SJ, Kimm K and Jung
MH: Glucose transporter 1 (GLUT1) expression is associated with
intestinal type of gastric carcinoma. J Korean Med Sci. 15:420–424.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Berthe A, Flament S, Grandemange S,
Zaffino M, Boisbrun M and Mazerbourg S: Δ2-Troglitazone promotes
cytostatic rather than pro-apoptotic effects in breast cancer cells
cultured in high serum conditions. Cell Cycle. 15:3402–3412. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Go S, Kramer TT, Verhoeven AJ, Oude ER and
Chang JC: The extracellular lactate-to-pyruvate ratio modulates the
sensitivity to oxidative stress-induced apoptosis via the cytosolic
NADH/NAD+ redox state. Apoptosis. 26:38–51. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ferrer CM, Lynch TP, Sodi VL, Falcone JN,
Schwab LP, Peacock DL, Vocadlo DJ, Seagroves TN and Reginato MJ:
O-GlcNAcylation regulates cancer metabolism and survival stress
signaling via regulation of the HIF-1 pathway. Mol Cell.
54:820–831. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Blum A, Mostow K, Jackett K, Kelty E,
Dakpa T, Ryan C and Hagos E: KLF4 regulates metabolic homeostasis
in response to stress. Cells. 10:8302021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Harris JC, Scully MA and Day ES: Cancer
cell membrane-coated nanoparticles for cancer management. Cancers
(Basel). 11:18362019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu X, Nie L, Zhang Y, Yan Y, Wang C,
Colic M, Olszewski K, Horbath A, Chen X, Lei G, et al: Actin
cytoskeleton vulnerability to disulfide stress mediates
disulfidptosis. Nat Cell Biol. 25:404–414. 2023. View Article : Google Scholar : PubMed/NCBI
|
